Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Aug-24 6:25 PM View:  | Ardelyx, Inc. (ARDX) | 20-Aug-24 | Private Sale | 5,289 | $5.86 | $30,995.10 | (2%) 300.55K to 295.26K | |
| 23-May-24 4:15 PM View: | Ardelyx, Inc. (ARDX) | 21-May-24 | Private Sale | 5,167 | $7.81 | $40,359.40 | (2%) 305.71K to 300.55K | |
| 22-Feb-24 5:01 PM View: | Ardelyx, Inc. (ARDX) | 20-Feb-24 | Private Sale | 5,341 | $8.75 | $46,714.00 | (2%) 310.18K to 304.83K | |
| 18-Jan-24 4:36 PM View: | Ardelyx, Inc. (ARDX) | 16-Jan-24 | Grant | 127,750 | -- | -- | 70% 182.43K to 310.18K | |
| 28-Dec-23 5:44 PM View: | Ardelyx, Inc. (ARDX) | 26-Dec-23 | Option Exercise | 75,000 | $0.99 | $74,250.00 | 23% 332.43K to 407.43K | 1% |
| 28-Dec-23 5:44 PM View: | Ardelyx, Inc. (ARDX) | 26-Dec-23 | Planned Private Option Sale | 75,000 | $6.36 | $476,708.00 | (18%) 407.43K to 332.43K | |
| 28-Dec-23 5:44 PM View: | Ardelyx, Inc. (ARDX) | 26-Dec-23 | Sale (Planned) | 150,000 | $6.36 | $953,415.00 | (45%) 332.43K to 182.43K | |
| 22-Nov-23 5:20 PM View: | Ardelyx, Inc. (ARDX) | 20-Nov-23 | Private Sale | 2,873 | $4.36 | $12,532.60 | (< 1%) 335.3K to 332.43K | |
| 23-Aug-23 4:42 PM View: | Ardelyx, Inc. (ARDX) | 21-Aug-23 | Private Sale | 2,884 | $3.55 | $10,243.40 | (< 1%) 336.73K to 333.85K | |
| 25-May-23 8:53 AM View: | Ardelyx, Inc. (ARDX) | 23-May-23 | Private Sale | 2,873 | $3.65 | $10,495.60 | (< 1%) 339.61K to 336.73K | |
| 24-Feb-23 5:37 PM View: | Ardelyx, Inc. (ARDX) | 21-Feb-23 | Private Sale | 3,439 | $3.00 | $10,320.40 | (1%) 340.05K to 336.61K | |
| 06-Jan-23 4:25 PM View: | Ardelyx, Inc. (ARDX) | 05-Jan-23 | Grant | 78,000 | -- | -- | 30% 262.05K to 340.05K | |
| 23-Nov-22 4:14 PM View: | Ardelyx, Inc. (ARDX) | 22-Nov-22 | Private Sale | 1,504 | $1.95 | $2,931.27 | (< 1%) 263.55K to 262.05K | |
| 01-Sep-22 7:04 PM View: | Ardelyx, Inc. (ARDX) | 31-Aug-22 | Private Purchase | 3,000 | $0.62 | $1,856.40 | 1% 260.55K to 263.55K | |
| 24-Aug-22 5:42 PM View: | Ardelyx, Inc. (ARDX) | 22-Aug-22 | Market Sale | 1,498 | $0.98 | $1,473.52 | (< 1%) 262.05K to 260.55K | (2%) |
| 08-Jun-22 8:03 PM View: | Ardelyx, Inc. (ARDX) | 06-Jun-22 | Sale | 73,312 | $0.65 | $47,695.60 | (22%) 335.36K to 262.05K | |
| 23-May-22 4:36 PM View: | Ardelyx, Inc. (ARDX) | 20-May-22 | Sale | 1,528 | $0.67 | $1,025.90 | (< 1%) 336.89K to 335.36K | |
| 25-Feb-22 10:00 PM View: | Ardelyx, Inc. (ARDX) | 22-Feb-22 | Sale | 1,800 | $0.67 | $1,206.00 | (< 1%) 335.69K to 333.89K | |
| 12-Jan-22 7:48 PM View: | Ardelyx, Inc. (ARDX) | 06-Jan-22 | Grant | 42,000 | -- | -- | 14% 293.69K to 335.69K | |
| 24-Nov-21 4:07 PM View: | Ardelyx, Inc. (ARDX) | 22-Nov-21 | Market Sale | 643 | $0.99 | $637.79 | (< 1%) 294.33K to 293.69K | 8% |
| 29-Oct-21 7:55 PM View: | Ardelyx, Inc. (ARDX) | 08-Oct-21 | Grant | 250,000 | -- | -- | 564% 44.33K to 294.33K | |
| 24-Aug-21 6:07 PM View: | Ardelyx, Inc. (ARDX) | 20-Aug-21 | Market Sale | 631 | $1.32 | $832.92 | (2%) 40.68K to 40.05K | (9%) |
| 21-May-21 4:48 PM View: | Ardelyx, Inc. (ARDX) | 20-May-21 | Market Sale | 612 | $7.09 | $4,337.73 | (1%) 41.29K to 40.68K | 4% |
| 24-Feb-21 4:37 PM View: | Ardelyx, Inc. (ARDX) | 22-Feb-21 | Market Sale | 608 | $6.88 | $4,184.56 | (1%) 41.9K to 41.29K | < 1% |
| 07-Jan-21 7:14 PM View: | Ardelyx, Inc. (ARDX) | 05-Jan-21 | Grant | 32,612 | -- | -- | 351% 9.29K to 41.9K | |
| 17-Sep-20 6:32 PM View: | Ardelyx, Inc. (ARDX) | 15-Sep-20 | Market Sale | 3,714 | $5.49 | $20,372.80 | (29%) 13.0K to 9.29K | (28%) |
| 09-Jun-20 8:15 PM View: | Ardelyx, Inc. (ARDX) | 08-Jun-20 | Grant | 10,000 | -- | -- | 333% 3.0K to 13.0K | |
| 14-Nov-16 5:49 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 09-Nov-16 | Market Sale | 4,342 | $8.19 | $35,544.50 | (18%) 23.52K to 19.17K | (78%) |
| 08-Nov-16 4:11 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 05-Nov-16 | Option Exercise | 15,000 | -- | -- | 176% 8.52K to 23.52K | |
| 06-Apr-15 5:53 PM View: | Karyopharm Therapeutics, Inc. (KPTI) | 02-Apr-15 | Market Purchase | 5,000 | $29.71 | $148,557.00 | 100% 0 to 5.0K | (51%) |
| 12-Feb-14 4:07 PM View: | Epirus Biopharmaceuticals, ... (ZLCS) | 10-Feb-14 | Grant | 250,000 | -- | -- | 100% 0 to 250.0K |